Bring Innovative Products to Our Customers
Resources
BOC Sciences is committed to providing one-stop Proteolysis Targeting Chimeric (PROTAC®), which has become a promising strategy in the field of drug discovery.
An Overview of Membrane-Associated E3 Ubiquitin Ligases
Comprehensive review of membrane E3 ubiquitin ligases in protein degradation.
Application of PROTAC in the Treatment of NSCLC
In the realm of NSCLC, common mutated targets such as KRAS, EGFR, and ALK have been effectively degraded in preclinical studies using PROTAC technology.
BioPROTAC: A Complementary Approach of PROTAC for Protein Degradation
Discover BioPROTAC technology complementing standard PROTAC methods in drug design.
Design Principles of PROTAC Delivery Systems
Key principles for designing effective PROTAC delivery platforms and formulations.
Development of Deubiquitinase-targeting Chimeras (DUBTACs)
Insight into the latest advances in developing DUBTACs for disease treatment.
Emergence of Research in Pro-PROTACs
Review of emerging studies and innovations in Pro-PROTAC therapeutics.
Want to join us?
At BOC Sciences, you will work with people who are enthusiastic and passionate about science and technology.
Join our team and build your career with us!
About Us
As a leading service provider in drug discovery and research, BOC Sciences is fully capable and committed to
providing one-stop Proteolysis Targeting Chimeric (PROTAC®) services to customers around the world to meet new drug discovery goals.
Professional Teams
Standard Workflow
Advanced Facilities
